TRxADE HEALTH, Inc. (MEDS)

USD 7.59

(4.55%)

Total Debt Summary of TRxADE HEALTH, Inc.

  • TRxADE HEALTH, Inc.'s latest annual total debt in 2023 was 7.1 Million USD , up 348.51% from previous year.
  • TRxADE HEALTH, Inc.'s latest quarterly total debt in 2024 Q2 was 193.6 Thousand USD , down -3.96% from previous quarter.
  • TRxADE HEALTH, Inc. reported annual total debt of 1.58 Million USD in 2022, up 26.86% from previous year.
  • TRxADE HEALTH, Inc. reported annual total debt of 1.24 Million USD in 2021, up 98.98% from previous year.
  • TRxADE HEALTH, Inc. reported quarterly total debt of 201.58 Thousand USD for 2024 Q1, down -97.16% from previous quarter.
  • TRxADE HEALTH, Inc. reported quarterly total debt of 7.1 Million USD for 2023 FY, up 348.51% from previous quarter.

Annual Total Debt Chart of TRxADE HEALTH, Inc. (2023 - 2006)

Historical Annual Total Debt of TRxADE HEALTH, Inc. (2023 - 2006)

Year Total Debt Total Debt Growth
2023 7.1 Million USD 348.51%
2022 1.58 Million USD 26.86%
2021 1.24 Million USD 98.98%
2020 627.45 Thousand USD -37.12%
2019 997.81 Thousand USD 18.22%
2018 844.05 Thousand USD 26.67%
2017 666.36 Thousand USD -14.72%
2016 781.35 Thousand USD -29.46%
2015 1.1 Million USD 0.0%
2014 - USD -100.0%
2013 19.33 Thousand USD 0.0%
2012 - USD 0.0%
2008 19.33 Million USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Total Debt Comparison of TRxADE HEALTH, Inc.

Name Total Debt Total Debt Difference
CannBioRx Life Sciences Corp. 1.32 Million USD -438.147%
BIMI International Medical Inc. 5.45 Million USD -30.219%
China Jo-Jo Drugstores, Inc. 43.21 Million USD 83.563%
Harrow Health, Inc. 8.625% Senior Notes due 2026 190.5 Million USD 96.271%
Harrow Health, Inc. 11.875% Senior Notes due 2027 183.17 Million USD 96.122%
Leafly Holdings, Inc. 29.08 Million USD 75.575%
Leafly Holdings, Inc. 29.08 Million USD 75.575%
LifeMD, Inc. 18.93 Million USD 62.477%
LifeMD, Inc. 18.93 Million USD 62.477%
PetMed Express, Inc. 1.45 Million USD -388.577%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 99.926%